Insulin glargine: the first clinically useful extended-acting insulin in half a century?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Monomeric insulins obtained by protein engineering and their medical implications
1988 • 493 citations
Relation of diabetic control to development of microvascular complications
1978 • 434 citations
Crystalline and Amorphous Insulin-Zinc Compounds with Prolonged Action
1952 • 137 citations
Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells
1997 • 110 citations
The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin
1998 • 95 citations
Absorption of isophane (NPH) insulin and its clinical implications.
1982 • 91 citations
STUDIES ON INSULIN WITH PROTAMINE
1936 • 71 citations
Characterization of proinsulin-insulin intermediates in human plasma.
1978 • 66 citations
NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
1989 • 59 citations
Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain
1987 • 50 citations
In vitro activity of biosynthetic human diarginylinsulin
1990 • 23 citations
Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics.
1985 • 21 citations
Effect of Raising Injection-Site Skin Temperature on Isophane (NPH) Insulin Crystal Dissociation
1989 • 18 citations